Association of plasma advanced glycation end‐products and their soluble receptor with type 2 diabetes among Chinese adults
Diabetes/Metabolism Research and Reviews · 2024
DOI: 10.1002/dmrr.3735 ↗At a glance
Journal article in Diabetes/Metabolism Research and Reviews, 2024. Written by Liangkai Chen and 8 co-authors. Institution: Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhon…. Major MEDLINE topics: Diabetes Mellitus, Type 2. Cited 10 times so far (Crossref); 37 references. Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation, National Key Research and Development Program of China.
Topics: Diabetes mellitus
Abstract (original language)
Aims
Population‐based evidence regarding circulating advanced glycation end‐products (AGEs) and the risk of type 2 diabetes (T2D) is conflicting and insufficient. We aimed to examine the association of plasma AGEs and plasma soluble receptors for AGEs (sRAGE) with T2D. Materials and Methods We conducted a hospital‐based case–control study including 1072 pairs (53.9 ± 9.7 years, 56.0% male) of newly diagnosed T2D and age‐ and sex‐matched controls. We further performed a nested case–control study within an ongoing prospective cohort consisting of 127 incident T2D cases and 381 well‐matched controls (62.2 ± 5.1 years, 71.7% male). Plasma AGEs were detected using liquid chromatography–tandem mass spectrometry, and plasma sRAGE was measured by enzyme‐linked immunosorbent assay. Conditional logistic regression was used to evaluate the association of plasma AGEs and sRAGE concentrations with T2D.
Results
Higher plasma AGEs and lower sRAGE concentrations were associated with higher odds of T2D. The multivariable‐adjusted odds ratios of T2D comparing the highest with the lowest quartile levels were 3.28 (95% CI: 2.14, 5.02) for plasma AGEs and 0.25 (95% CI: 0.16, 0.39) for plasma sRAGE. Participants in the highest quartile of plasma AGEs and the lowest quartile of sRAGE concentrations had the greatest odds of T2D. The positive association of AGEs and inverse association of sRAGE with T2D risk was confirmed in the replication‐nested case–control study.
Conclusions
Increased circulating AGEs and decreased sRAGE concentrations were associated with elevated T2D risk. Our findings may have implications for the strategies of T2D prevention and management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
- BYHEALTH Institute of Nutrition & Health, Guangzhou, China.
ORCID profiles: Liangkai Chen, Liegang Liu
Funding
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- National Key Research and Development Program of China
Cite
APA
Chen, L., Wang, Q., Lv, Y., Xu, W., Jiang, G., Li, Y., Luo, P., He, R., & Liu, L. (2024). Association of plasma advanced glycation end‐products and their soluble receptor with type 2 diabetes among Chinese adults. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3735
Vancouver
Chen L, Wang Q, Lv Y, Xu W, Jiang G, Li Y, et al. Association of plasma advanced glycation end‐products and their soluble receptor with type 2 diabetes among Chinese adults. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3735
BibTeX
@article{Chen2024,
author = {Chen, Liangkai and Wang, Qiang and Lv, Yanling and Xu, Wenyuan and Jiang, Guanhua and Li, Yonggang and Luo, Ping and He, Ruikun and Liu, Liegang},
title = {Association of plasma advanced glycation end‐products and their soluble receptor with type 2 diabetes among Chinese adults},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2024},
doi = {10.1002/dmrr.3735}
}
EUVIMED